Aging-Dependent Mitophagy Dysfunction in Alzheimer’s Disease

被引:0
作者
Mingxue Song
Xiulan Zhao
Fuyong Song
机构
[1] Cheeloo College of Medicine,Department of Toxicology and Nutrition, School of Public Health
[2] Shandong University,undefined
来源
Molecular Neurobiology | 2021年 / 58卷
关键词
Alzheimer’s disease; mitochondrial dysfunction; mitophagy; neuroinflammation;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer’s disease (AD) is the most common late-onset dementia characterized by the deposition of extracellular amyloid plaques and formation of intracellular neurofibrillary tangles, which eventually lead to neuronal loss and cognitive deficits. Multiple lines of evidence indicate that mitochondrial dysfunction is involved in the initiation and progression of AD. As essential machinery for mitochondrial quality control, mitophagy plays a housekeeping role in neuronal cells by eliminating dysfunctional or excessive mitochondria. At present, mounting evidence support that the activity of mitophagy markedly declines in human brains during aging. Impaired mitophagy and mitochondrial dysfunction were causally linked to bioenergetic deficiency, oxidative stress, microglial activation, and chronic inflammation, thereby aggravating the Aβ and tau pathologies and leading to neuron loss in AD. This review summarizes recent evidence for age-associated mitophagy decline during human aging and provides an overview of mitochondrial dysfunction involved in the process of AD. It also discusses the underlying mechanisms through which defective mitophagy leads to neuronal cell death in AD. Therapeutic interventions aiming to restore mitophagy functions can be used as a strategy for ameliorating AD pathogenesis.
引用
收藏
页码:2362 / 2378
页数:16
相关论文
共 1151 条
[1]  
Hampel H(2011)The future of Alzheimer’s disease: the next 10 years Prog Neurobiol 95 718-728
[2]  
Prvulovic D(1991)The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’s disease Neurobiol Aging 12 295-312
[3]  
Teipel S(2010)Alzheimer’s disease: strategies for disease modification Nat Rev Drug Discov 9 387-398
[4]  
Jessen F(2019)Dysfunctional mitochondria and mitophagy as drivers of Alzheimer’s disease pathogenesis Front Aging Neurosci 11 311-1416
[5]  
Luckhaus C(2020)Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances Mol Neurodegener 15 30-412
[6]  
Frolich L(2018)Mitochondria and mitochondrial cascades in Alzheimer’s disease J Alzheimers Dis 62 1403-166
[7]  
Riepe MW(2019)Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease Nat Neurosci 22 401-3088
[8]  
Dodel R(2017)Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms Trends Neurosci 40 151-106
[9]  
Leyhe T(2020)Mitochondrial dysfunction: a potential therapeutic target to treat Alzheimer’s disease Mol Neurobiol 57 3075-963
[10]  
Bertram L(2016)Dementia Collaborators A: Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 Lancet Neurol 2019 88-441